Las ventas del medicamento Keytruda, un anticuerpo monoclonal indicado frente a varios tipos de cáncer, alcanzaron los 29.500 millones de dólares (27.300 millones de euros) tras crecer un 18% el ...

Most people receive Keytruda infusions for up to 2 years. But in some cases, treatment may last longer if there’s evidence that the drug is still effective and the side effects are minimal.

Keytruda (pembrolizumab) is prescribed to treat melanoma and other conditions by reviving the body’s immune system. Your response to this drug may vary based on your medical history, diagnosis ...

Existe en todos los sectores, como el de la medicina. ... Y en ese campo, Keytruda es el medicamento más vendido del mundo con casi 30 mil millones de dólares en ventas en 2024. ¿Y qué le hace ...

En las últimas semanas, su nombre está por todas partes. Keytruda está haciendo historia en cuanto a ventas de medicamentos se refiere, habiendo disparado un 18% sus ventas en 2024 y alcanzando ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo. The conversion to ...

There are concerns about Merck’s ability to successfully navigate the loss of exclusivity period for its blockbuster drug, Keytruda, and potential competition for Keytruda. With a weak fourth ...

Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA ® or OPDIVO ® can result in improved patient outcomes - MDSCs – Myeloid Derived Suppressor Cells in the ...

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...

Durante la tarde de este miércoles, el primer mandatario de EEUU comunicó los “aranceles recíprocos” que venía vaticinando desde hace días, a una lista de 185 países, incluido Chile. Durante su ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...